Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Ferrando-Martinez

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
The Journal of Infectious Diseases|November 27, 2013
Hepatitis C therapy with interferon-α and ribavirin reduces CD4 T-cell-associated HIV-1 DNA in HIV-1/hepatitis C virus-coinfected patientsHong Sun, Maria J Buzon, Amy Shaw, et al.
The Journal of Clinical Investigation|April 26, 2014
Intrinsic TGF-β signaling promotes age-dependent CD8+ T cell polyfunctionality attritionRajarshi Bhadra, Magali M Moretto, Julio C Castillo, et al.
AIDS (London, England)|February 4, 2012
CD4 T-cell regeneration in HIV-1 elite controllersYue Yang, Maha Al-Mozaini, Maria J Buzon, et al.
Antimicrobial Agents and Chemotherapy|May 2, 2012
HIV-1 tropism evolution after short-term maraviroc monotherapy in HIV-1-infected patientsAlejandro Gonzalez-Serna, María Concepción Romero-Sánchez, Sara Ferrando-Martinez, et al.
Frontiers in Immunology|January 9, 2019
Immune Correlates of Natural HIV Elite Control and Simultaneous HCV Clearance-SupercontrollersBeatriz Dominguez-Molina, Sara Ferrando-Martinez, Laura Tarancon-Diez, et al.
Antimicrobial Agents and Chemotherapy|September 6, 2012
Effect of maraviroc on HIV disease progression-related biomarkersM Concepción Romero-Sánchez, Kawthar Machmach, Alejandro Gonzalez-Serna, et al.
Journal for Immunotherapy of Cancer|March 12, 2024
rhIL-7-hyFc and hIL-2/TCB2c combination promotes an immune-stimulatory tumor microenvironment that improves antitumor efficacy of checkpoint inhibitorsMinji Lee, Sun-Kyoung Im, Seungtae Baek, et al.
The Journal of Experimental Medicine|September 23, 2020
Immunotherapy during the acute SHIV infection of macaques confers long-term suppression of viremiaYoshiaki Nishimura, Olivia K Donau, Joana Dias, et al.
Plos One|December 19, 2015
Selective Loss of Early Differentiated, Highly Functional PD1high CD4 T Cells with HIV ProgressionRobert M Paris, Constantinos Petrovas, Sara Ferrando-Martinez, et al.
Journal of Hepatology|March 8, 2022
Immunological biomarker discovery in cure regimens for chronic hepatitis B virus infectionAdam J Gehring, Patricia Mendez, Kirsten Richter, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
The Journal of Infectious Diseases|November 27, 2013
Hepatitis C therapy with interferon-α and ribavirin reduces CD4 T-cell-associated HIV-1 DNA in HIV-1/hepatitis C virus-coinfected patientsHong Sun, Maria J Buzon, Amy Shaw, et al.
The Journal of Clinical Investigation|April 26, 2014
Intrinsic TGF-β signaling promotes age-dependent CD8+ T cell polyfunctionality attritionRajarshi Bhadra, Magali M Moretto, Julio C Castillo, et al.
AIDS (London, England)|February 4, 2012
CD4 T-cell regeneration in HIV-1 elite controllersYue Yang, Maha Al-Mozaini, Maria J Buzon, et al.
Antimicrobial Agents and Chemotherapy|May 2, 2012
HIV-1 tropism evolution after short-term maraviroc monotherapy in HIV-1-infected patientsAlejandro Gonzalez-Serna, María Concepción Romero-Sánchez, Sara Ferrando-Martinez, et al.
Frontiers in Immunology|January 9, 2019
Immune Correlates of Natural HIV Elite Control and Simultaneous HCV Clearance-SupercontrollersBeatriz Dominguez-Molina, Sara Ferrando-Martinez, Laura Tarancon-Diez, et al.
Antimicrobial Agents and Chemotherapy|September 6, 2012
Effect of maraviroc on HIV disease progression-related biomarkersM Concepción Romero-Sánchez, Kawthar Machmach, Alejandro Gonzalez-Serna, et al.
Journal for Immunotherapy of Cancer|March 12, 2024
rhIL-7-hyFc and hIL-2/TCB2c combination promotes an immune-stimulatory tumor microenvironment that improves antitumor efficacy of checkpoint inhibitorsMinji Lee, Sun-Kyoung Im, Seungtae Baek, et al.
The Journal of Experimental Medicine|September 23, 2020
Immunotherapy during the acute SHIV infection of macaques confers long-term suppression of viremiaYoshiaki Nishimura, Olivia K Donau, Joana Dias, et al.
Plos One|December 19, 2015
Selective Loss of Early Differentiated, Highly Functional PD1high CD4 T Cells with HIV ProgressionRobert M Paris, Constantinos Petrovas, Sara Ferrando-Martinez, et al.
Journal of Hepatology|March 8, 2022
Immunological biomarker discovery in cure regimens for chronic hepatitis B virus infectionAdam J Gehring, Patricia Mendez, Kirsten Richter, et al.
Pageof 4